Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.
about
Evolution of resistance to a last-resort antibiotic in Staphylococcus aureus via bacterial competitionHUMAN MICROBIOTA. Small molecules from the human microbiotaLessons learned from the transformation of natural product discovery to a genome-driven endeavorAntimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives.In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria.Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against StaphylococciGenome mining for ribosomally synthesized natural productsPersistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristicsMolecular distinctions exist between community-associated methicillin-resistant Staphylococcus aureus colonization and disease-associated isolates in childrenComplete genome sequence of a Pantón-Valentine leukocidin-negative community-associated methicillin-resistant Staphylococcus aureus strain of sequence type 72 from Korea.Genomic and transcriptomic differences in community acquired methicillin resistant Staphylococcus aureus USA300 and USA400 strains.Complete genome sequence of Staphylococcus aureus T0131, an ST239-MRSA-SCCmec type III clone isolated in China.Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.Gene cluster analysis for the biosynthesis of elgicins, novel lantibiotics produced by Paenibacillus elgii B69.Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with Methicillin-resistant S. aureus hospital-acquired infection in the United StatesIsolation, biochemical characterization, and cloning of a bacteriocin from the poultry-associated Staphylococcus aureus strain CH-91.Transcriptional analysis of the Streptococcus pyogenes salivaricin locus.Restoration of bioactive lantibiotic suicin from a remnant lan locus of pathogenic Streptococcus suis serotype 2.Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP.Increasing the success rate of lantibiotic drug discovery by Synthetic Biology.Genetic manipulation of Staphylococci-breaking through the barrier.Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials.Reduction of Lactobacillus in the milks of cows with subclinical mastitis.Antibiotics and specialized metabolites from the human microbiota.Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemiaIdentification of Putative Novel Class-I Lanthipeptides in Firmicutes: A Combinatorial Analysis Approach Performed on Genome Sequenced Bacteria and a Close Inspection of Z-Geobacillin Lanthipeptide Biosynthesis Gene Cluster of the Thermophilic sp. St
P2860
Q24490083-8DC8D5AE-DA4C-45A2-8844-310D3D2184AEQ26799980-406682FA-15C1-4916-9608-DC5242DDAB9BQ27007021-BB630333-AD53-4F90-ABC7-4D0684C785B9Q30399098-DC3FD8FE-81A8-40AD-931B-DB77CDA29C9EQ33759122-DD41E2F8-8C96-4418-A32B-11931FD7462EQ34095875-C6CAE2D3-3A7D-4528-A299-74DF225B27B2Q34151086-539F6D5A-E4D3-4ECA-B119-DEB4B662DA2AQ34778794-A5844B2F-11B7-4CE6-B9B7-C43D88D3B152Q34798700-5C6ED035-FA0C-40C3-A0EE-35D05369F4A1Q34974081-91904C13-F7ED-4702-B473-B55F372B7F1AQ34984553-2056C15C-61DD-4A9B-AEB3-815FA7E8ADADQ35096323-515F5213-6F39-4D2C-BD7C-A2C3E3694AC9Q35529780-CB32633E-13AA-4021-956A-E5F6F574F4F2Q35914371-324ECABF-487F-4D0F-9165-8E9FD026C200Q36025858-381A7D7B-5215-41CF-ABD5-082C1743311EQ37049158-C5BD70A3-6187-4E8B-A7EB-F9D839B26637Q37545660-62F5CB95-C61A-4652-9ED3-A73267CD0486Q37545841-C62ABAA5-C5F7-45E1-A3FC-76F7B707C6B9Q37657138-DE9CE74D-FFCB-41F7-8D63-2A4D9D15EA56Q38017216-62DA459D-8B42-4027-8254-9F51E15B20B2Q38037552-F63CA0BE-C329-42C1-BA81-D777418E08E9Q38945513-F31DBC95-F8D1-43EC-AD65-C90220E33FD2Q41357686-B6EA98D3-3DB2-42A8-B9C3-DB9613E34313Q41987403-56A12A62-F1EE-43BD-9962-D1C9118C1D1CQ58716354-E2BF4C8E-F141-411C-BFCB-F4FDE0E93110Q58760825-2DD5DEEE-F65E-4339-9C6B-EB3BA10069D2
P2860
Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.
@ast
Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.
@en
type
label
Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.
@ast
Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.
@en
prefLabel
Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.
@ast
Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.
@en
P2093
P2860
P50
P356
P1476
Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains
@en
P2093
Angela Rossney
Friedrich Götz
John R Tagg
Karen M Daly
Lorraine A Draper
Paula M O'Connor
Philip A Wescombe
Ralph W Jack
Stephanie K Sandiford
P2860
P304
P356
10.1128/JB.01375-09
P407
P577
2009-12-18T00:00:00Z